1. Home
  2. RLMD vs TRX Comparison

RLMD vs TRX Comparison

Compare RLMD & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • TRX
  • Stock Information
  • Founded
  • RLMD 2004
  • TRX 1990
  • Country
  • RLMD United States
  • TRX Canada
  • Employees
  • RLMD N/A
  • TRX N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • TRX
  • Sector
  • RLMD Health Care
  • TRX
  • Exchange
  • RLMD Nasdaq
  • TRX Nasdaq
  • Market Cap
  • RLMD 110.6M
  • TRX 109.5M
  • IPO Year
  • RLMD N/A
  • TRX N/A
  • Fundamental
  • Price
  • RLMD $2.75
  • TRX $0.36
  • Analyst Decision
  • RLMD Hold
  • TRX Strong Buy
  • Analyst Count
  • RLMD 2
  • TRX 2
  • Target Price
  • RLMD $7.50
  • TRX $1.58
  • AVG Volume (30 Days)
  • RLMD 126.6K
  • TRX 405.5K
  • Earning Date
  • RLMD 11-07-2024
  • TRX 01-13-2025
  • Dividend Yield
  • RLMD N/A
  • TRX N/A
  • EPS Growth
  • RLMD N/A
  • TRX N/A
  • EPS
  • RLMD N/A
  • TRX N/A
  • Revenue
  • RLMD N/A
  • TRX $36,723,000.00
  • Revenue This Year
  • RLMD N/A
  • TRX $26.24
  • Revenue Next Year
  • RLMD N/A
  • TRX $43.48
  • P/E Ratio
  • RLMD N/A
  • TRX N/A
  • Revenue Growth
  • RLMD N/A
  • TRX 4.44
  • 52 Week Low
  • RLMD $1.88
  • TRX $0.31
  • 52 Week High
  • RLMD $7.22
  • TRX $0.49
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 23.58
  • TRX 32.59
  • Support Level
  • RLMD $2.96
  • TRX $0.35
  • Resistance Level
  • RLMD $3.43
  • TRX $0.38
  • Average True Range (ATR)
  • RLMD 0.21
  • TRX 0.01
  • MACD
  • RLMD -0.07
  • TRX -0.00
  • Stochastic Oscillator
  • RLMD 1.60
  • TRX 10.20

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About TRX TRX Gold Corporation

TRX Gold Corp, formerly Tanzanian Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. Its projects include the Buckreef project, Kigosi project, and Itetemia Gold project whereas, its exploration stage project consists of the Lunguya project and the Luhala project.

Share on Social Networks: